164 related articles for article (PubMed ID: 30673295)
81. Stereotactic Radiation Therapy for De Novo Head and Neck Cancers: A Systematic Review and Meta-Analysis.
Malik NH; Kim MS; Chen H; Poon I; Husain Z; Eskander A; Boldt G; Louie AV; Karam I
Adv Radiat Oncol; 2021; 6(1):100628. PubMed ID: 33665492
[TBL] [Abstract][Full Text] [Related]
82. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Brunner TB; Blanck O; Lewitzki V; Abbasi-Senger N; Momm F; Riesterer O; Duma MN; Wachter S; Baus W; Gerum S; Guckenberger M; Gkika E
Radiother Oncol; 2019 Mar; 132():42-47. PubMed ID: 30825968
[TBL] [Abstract][Full Text] [Related]
83. The Evolving Role of Radiation Therapy in the Treatment of Biliary Tract Cancer.
Gkika E; Hawkins MA; Grosu AL; Brunner TB
Front Oncol; 2020; 10():604387. PubMed ID: 33381458
[TBL] [Abstract][Full Text] [Related]
84. Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Smart AC; Goyal L; Horick N; Petkovska N; Zhu AX; Ferrone CR; Tanabe KK; Allen JN; Drapek LC; Qadan M; Murphy JE; Eyler CE; Ryan DP; Hong TS; Wo JY
Ann Surg Oncol; 2020 Apr; 27(4):1122-1129. PubMed ID: 31873931
[TBL] [Abstract][Full Text] [Related]
85. Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma.
Sebastian NT; Tan Y; Miller ED; Williams TM; Alexandra Diaz D
Clin Transl Radiat Oncol; 2019 Nov; 19():66-71. PubMed ID: 31517072
[TBL] [Abstract][Full Text] [Related]
86. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
[TBL] [Abstract][Full Text] [Related]
87. Hypofractionated Radiation Therapy: A Potential Option for Advanced Intrahepatic Cholangiocarcinoma.
Shindoh J
Ann Surg Oncol; 2020 Apr; 27(4):983-984. PubMed ID: 31848809
[No Abstract] [Full Text] [Related]
88. Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation.
Yankey H; Ruth KJ; Dotan E; Reddy S; Meyer JE
Adv Radiat Oncol; 2024 Apr; 9(4):101412. PubMed ID: 38778829
[TBL] [Abstract][Full Text] [Related]
89. The Current Role of Radiation in the Management of Cholangiocarcinoma-A Narrative Review.
Verma S; Grindrod N; Breadner D; Lock M
Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730728
[TBL] [Abstract][Full Text] [Related]
90. British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma.
Rushbrook SM; Kendall TJ; Zen Y; Albazaz R; Manoharan P; Pereira SP; Sturgess R; Davidson BR; Malik HZ; Manas D; Heaton N; Prasad KR; Bridgewater J; Valle JW; Goody R; Hawkins M; Prentice W; Morement H; Walmsley M; Khan SA
Gut; 2023 Dec; 73(1):16-46. PubMed ID: 37770126
[TBL] [Abstract][Full Text] [Related]
91. Proton beam therapy for extrahepatic biliary tract cancer: Analysis with prospective multi-institutional patients' registration database, Proton-Net.
Yamazaki H; Shibuya K; Kimoto T; Suzuki M; Murakami M; Terashima K; Okimoto T; Iizumi T; Sakurai H; Wakatsuki M; Suzuki O; Katoh N; Arimura T; Ogino T; Takagi M; Araya M; Waki T; Matsumoto S; Ogino H; Fukumoto T; Ohtsuka M
Clin Transl Radiat Oncol; 2023 Jul; 41():100634. PubMed ID: 37234735
[TBL] [Abstract][Full Text] [Related]
92. Locoregional Therapy for Intrahepatic Cholangiocarcinoma.
Owen M; Makary MS; Beal EW
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190311
[TBL] [Abstract][Full Text] [Related]
93. Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma.
Jiang J; Diaz DA; Nuguru SP; Mittra A; Manne A
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612046
[TBL] [Abstract][Full Text] [Related]
94. Efficacy and Safety of External-beam Radiation Therapy for Unresectable Primary or Local Recurrent Cholangiocarcinoma.
Murakami T; Aizawa R; Matsuo Y; Hanazawa H; Taura K; Fukuda A; Uza N; Shiokawa M; Kanai M; Hatano E; Seno H; Muto M; Mizowaki T
Cancer Diagn Progn; 2022; 2(6):634-640. PubMed ID: 36340447
[TBL] [Abstract][Full Text] [Related]
95. The new insight of treatment in Cholangiocarcinoma.
Li Y; Song Y; Liu S
J Cancer; 2022; 13(2):450-464. PubMed ID: 35069894
[TBL] [Abstract][Full Text] [Related]
96. Non-surgical treatment of hilar cholangiocarcinoma.
Inchingolo R; Acquafredda F; Ferraro V; Laera L; Surico G; Surgo A; Fiorentino A; Marini S; de'Angelis N; Memeo R; Spiliopoulos S
World J Gastrointest Oncol; 2021 Nov; 13(11):1696-1708. PubMed ID: 34853644
[TBL] [Abstract][Full Text] [Related]
97. Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma.
Renzulli M; Ramai D; Singh J; Sinha S; Brandi N; Ierardi AM; Albertini E; Sacco R; Facciorusso A; Golfieri R
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283065
[TBL] [Abstract][Full Text] [Related]
98. Stereotactic radiotherapy in intrahepatic cholangiocarcinoma: A systematic review.
Bisello S; Camilletti AC; Bertini F; Buwenge M; Arcelli A; Macchia G; Deodato F; Cilla S; Mattiucci G; Autorino R; Brandi G; Strigari L; Cammelli S; Morganti AG
Mol Clin Oncol; 2021 Aug; 15(2):152. PubMed ID: 34141431
[TBL] [Abstract][Full Text] [Related]
99. Progress toward improving outcomes in patients with cholangiocarcinoma.
Kawasaki H; Akazawa Y; Razumilava N
Curr Treat Options Gastroenterol; 2021 Mar; 19(1):153-168. PubMed ID: 33883870
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
